Logo image of VER-H.CA

VERISANTE TECHNOLOGY INC (VER-H.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:VER-H - CA92346G2036 - Common Stock

0.015 CAD
-0.01 (-25%)
Last: 12/19/2025, 7:00:00 PM
Fundamental Rating

0

Overall VER-H gets a fundamental rating of 0 out of 10. We evaluated VER-H against 15 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of VER-H have multiple concerns. VER-H has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year VER-H has reported negative net income.
VER-H had negative earnings in 4 of the past 5 years.
In the past 5 years VER-H always reported negative operating cash flow.
VER-H.CA Yearly Net Income VS EBIT VS OCF VS FCFVER-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

VER-H has a Return On Assets of -2017.86%. This is amonst the worse of the industry: VER-H underperforms 86.67% of its industry peers.
Industry RankSector Rank
ROA -2017.86%
ROE N/A
ROIC N/A
ROA(3y)44.81%
ROA(5y)-78.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VER-H.CA Yearly ROA, ROE, ROICVER-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for VER-H so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VER-H.CA Yearly Profit, Operating, Gross MarginsVER-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

0

2. Health

2.1 Basic Checks

VER-H has more shares outstanding than it did 1 year ago.
VER-H has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, VER-H has a worse debt to assets ratio.
VER-H.CA Yearly Shares OutstandingVER-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VER-H.CA Yearly Total Debt VS Total AssetsVER-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

Based on the Altman-Z score of -6128.08, we must say that VER-H is in the distress zone and has some risk of bankruptcy.
VER-H has a worse Altman-Z score (-6128.08) than 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6128.08
ROIC/WACCN/A
WACCN/A
VER-H.CA Yearly LT Debt VS Equity VS FCFVER-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

2.3 Liquidity

A Current Ratio of 0.18 indicates that VER-H may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.18, VER-H is doing worse than 60.00% of the companies in the same industry.
VER-H has a Quick Ratio of 0.18. This is a bad value and indicates that VER-H is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.18, VER-H is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18
VER-H.CA Yearly Current Assets VS Current LiabilitesVER-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.13% over the past year.
EPS 1Y (TTM)16.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VER-H.CA Yearly Revenue VS EstimatesVER-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 50K 100K 150K 200K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
VER-H.CA Price Earnings VS Forward Price EarningsVER-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VER-H.CA Per share dataVER-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0 0 0 0

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VER-H does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

VERISANTE TECHNOLOGY INC

TSX-V:VER-H (12/19/2025, 7:00:00 PM)

0.015

-0.01 (-25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners76.06%
Ins Owner ChangeN/A
Market Cap659.10K
Revenue(TTM)N/A
Net Income(TTM)-113.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2017.86%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)44.81%
ROA(5y)-78.45%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z -6128.08
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y74.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.71%
OCF growth 3YN/A
OCF growth 5YN/A

VERISANTE TECHNOLOGY INC / VER-H.CA FAQ

What is the ChartMill fundamental rating of VERISANTE TECHNOLOGY INC (VER-H.CA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to VER-H.CA.


What is the valuation status of VERISANTE TECHNOLOGY INC (VER-H.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to VERISANTE TECHNOLOGY INC (VER-H.CA). This can be considered as Overvalued.


How profitable is VERISANTE TECHNOLOGY INC (VER-H.CA) stock?

VERISANTE TECHNOLOGY INC (VER-H.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for VER-H stock?

The financial health rating of VERISANTE TECHNOLOGY INC (VER-H.CA) is 0 / 10.